Histone H3 E50K mutation confers oncogenic activity and supports an EMT phenotype.

Sad, K; Jones, C Y; Adams, M; Lustenberger, S; Lee, R S; Elayavalli, S R; Farhi, J; Lemon, L D; Fasken, M B; Corbett, A H; Spangle, J M

Sad, K; Jones, C Y; Adams, M; Lustenberger, S; Lee, R S; Elayavalli, S R; Farhi, J; Lemon, L D; Fasken, M B; Corbett, A H; Spangle, J M.

Afiliação

Sad K; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322.
Jones CY; Department of Biology; Emory College of Arts and Sciences, Atlanta GA 30322.
Adams M; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322.
Lustenberger S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA.
Lee RS; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322.
Elayavalli SR; Department of Biology; Emory College of Arts and Sciences, Atlanta GA 30322.
Farhi J; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322.
Lemon LD; Department of Biology; Emory College of Arts and Sciences, Atlanta GA 30322.
Fasken MB; Department of Biology; Emory College of Arts and Sciences, Atlanta GA 30322.
Corbett AH; Department of Biology; Emory College of Arts and Sciences, Atlanta GA 30322.
Spangle JM; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322.

bioRxiv ; 2023 Oct 12.

Article em En | MEDLINE | ID: mdl-37873162

Palavras-chave

EMT; cancer; chromatin modification; epigenetics; histone; oncohistone

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2023 Tipo de documento: Article